Under this collaborative agreement, the FDA will provide non-proprietary toxicology data for the following toxicological endpoints: carcinogenicity, genetic toxicity, reproductive toxicity, and ...

Acquisition deepens Revvity Signals’ presence in research informatics while furthering its ongoing expansion into development and manufacturing solutions ACD/Labs brings deep expertise in supporting ...